Octagon Capital Advisors LP Centessa Pharmaceuticals PLC Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
A detailed history of Octagon Capital Advisors LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Octagon Capital Advisors LP holds 2,345,075 shares of CNTA stock, worth $37.3 Million. This represents 4.9% of its overall portfolio holdings.
Number of Shares
2,345,075
Previous 2,060,100
13.83%
Holding current value
$37.3 Million
Previous $23.3 Million
9.03%
% of portfolio
4.9%
Previous 3.64%
Shares
4 transactions
Others Institutions Holding CNTA
# of Institutions
85Shares Held
96.9MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$317 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$158 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$154 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$90.8 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$76 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.5B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...